Olanzapine concentrations collected postmortem in patients treated with olanzapine long-acting injection

被引：1
|
作者：
McDonnell, D. P. [1 ]
Detke, H. C. [1 ]
Falk, M. [1 ]
Shatapathy, C. C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70776-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.053
引用
收藏
页码：S489 / S490
页数：2
相关论文
共 50 条
  • [21] Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism
    McDonnell, David P.
    Detke, Holland C.
    Bergstrom, Richard F.
    Kothare, Prajakti
    Johnson, Jason
    Stickelmeyer, Mary
    Sanchez-Felix, Manuel V.
    Sorsaburu, Sebastian
    Mitchell, Malcolm I.
    BMC PSYCHIATRY, 2010, 10
  • [22] Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
    Holland C Detke
    David P McDonnell
    Elizabeth Brunner
    Fangyi Zhao
    Sebastian Sorsaburu
    Victoria J Stefaniak
    Sara A Corya
    BMC Psychiatry, 10
  • [23] Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine
    McDonnell, David P.
    Kryzhanovskaya, Ludmila A.
    Zhao, Fangyi
    Detke, Holland C.
    Feldman, Peter D.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (06) : 422 - 433
  • [24] The Effect of Valproic Acid on Olanzapine Serum Concentration A Study Including 2791 Patients Treated With Olanzapine Tablets or Long-Acting Injections
    Tveito, Marit
    Smith, Robert Lovsletten
    Hoiseth, Gudrun
    Molden, Espen
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 561 - 566
  • [25] COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Carroll, S. M.
    Jemiai, N.
    Suter, B.
    O'Donohoe, P.
    Skjoldborg, U.
    Moller, J.
    Kleivenes, O. K.
    Novick, D.
    VALUE IN HEALTH, 2009, 12 (07) : A358 - A358
  • [26] Prevention of Catatonia With Olanzapine Long-Acting Injectable
    Ifteni, Petru-Iulian
    Teodorescu, Andreea
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E599 - E601
  • [27] Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
    Witte, Michael M.
    Case, Michael G.
    Schuh, Kory J.
    Ascher-Svanum, Haya
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 315 - 323
  • [28] Risk Minimization and Assessment of Olanzapine Long-Acting Injection in 21 Countries in Europe
    Jones, Meghan E.
    Detke, Holland C.
    Chhabra-Khanna, Rashna
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 476 - 476
  • [29] Acute Urinary Retention Associated with Olanzapine Long-acting Injection: A Case Report
    Kurariya, Astut
    Purohith, Abhiram N.
    Shenoy, Sonia
    Bhandary, Rajeshkrishna P.
    Sharma, Podila Satya Venkata Narasimha
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2024, 46 (03) : 279 - 280
  • [30] Olanzapine long-acting injection: insights from an early case series in the UK
    McGlennon, Deirdre
    Bushe, Chris J.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (05) : 189 - 193
12345